TwitterRSSFacebookDirectors Blog
  Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

You Are Here: Home  »  Research Funding  »  Funding Opportunities  » 

Skip secondary menu

NINDS Neuroscience Funding Announcements

Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers (U54)

Funding Contact(s): John Porter, Ph.D.
Funding Categories: Neurogenetics

Brief Description:

This funding opportunity announcement (FOA) solicits new (type 1) and competitive renewal (type 2) applications for the support of Senator Paul D. Wellstone Muscular Dystrophy Cooperative Research Centers. Successful applicants will join a network of existing Centers to foster the translation of new scientific findings and technological developments into novel treatments for the muscular dystrophies. Each Center may contain a mixture of basic, translational, or clinical research, as long as efforts are directed toward the steps required for therapeutic development, including therapeutic target identification, characterization, and validation, development of diagnostics and biomarkers to characterize or stratify patient populations, in vitro assay development, animal model development and characterization, candidate therapeutic efficacy screening, preclinical therapeutic optimization and FDA-required activities leading to an investigational new drug (IND) application, clinical infrastructure and studies in support of a clinical trial, patient-oriented natural history studies, and early stage clinical trials for one or more types of muscular dystrophy.

Grant Mechanism: U54
NIH Guide: RFA-NS-08-002
Release Date: 2007-08-08
Expiration Date: 2007-11-20